Financière de Tubize S.A.
TUB
Clasificación en acciones
#2220
Financière de Tubize SA, headquartered in Brussels, Belgium, operates as a... Financière de Tubize SA, headquartered in Brussels, Belgium, operates as a global biopharmaceutical firm, primarily through its investment in UCB. The company is dedicated to discovering and advancing innovative medicines and solutions focused on neurological and immunological disorders. Its current commercial offerings include Cimzia, an established treatment for a range of inflammatory conditions such as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis. For partial-onset seizures in epilepsy, it provides Briviact, Vimpat, and Keppra, alongside Nayzilam, a nasal spray. Neupro addresses Parkinson's disease and restless legs syndrome. Additionally, the portfolio features Evenity, an injectable therapy for osteoporosis, and Bimzelx, used to manage moderate to severe plaque psoriasis. The company's development pipeline highlights several promising candidates: Staccato, aimed at stereotypical prolonged seizures; Bepranemab for Alzheimer's disease; and UCB0599 for Parkinson's disease. Other therapies under investigation include bimekizumab, which targets psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; rozanolixizumab, for conditions like myasthenia gravis, immune thrombocytopenia, myelin oligodendrocyte glycoprotein antibody disease, and autoimmune encephalitis; and dapirolizumab pegol, intended for systemic lupus erythematosus.
Precio por acción
$203.04
Capitalización bursátil
$9.04B
Cambio (1 día)
-7.47%
Cambio (1 año)
-25.36%
País
BE
Comercio Financière de Tubize S.A. (TUB)
Categoría
Healthcare
Historial de desdoblamientos de acciones de Financière de Tubize S.A. (TUB)
La acción Financière de Tubize S.A. (símbolo: TUB) tuvo un total de 3 desdoblamientos.
El desdoblamiento más reciente ocurrió el Jun 17, 2005.
Una acción TUB comprada antes de May 24, 1988 equivaldría hoy a 211.6 acciones TUB.
El desdoblamiento más reciente ocurrió el Jun 17, 2005.
Una acción TUB comprada antes de May 24, 1988 equivaldría hoy a 211.6 acciones TUB.
Lista de desdoblamientos de acciones
| Año | Desdoblamiento | Multiplicador | Multiplicador acumulado |
|---|---|---|---|
| 2005-06-17 | 2:1 | x2 | x211.6 |
| 1999-11-26 | 100:1 | x100 | x105.8 |
| 1988-05-24 | 529:500 | x1.058 | x1.058 |
Desdoblamientos de acciones de empresas similares o competidoras
| Empresa | Número de desdoblamientos de acciones | Multiplicador acumulado | País |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
